← Back to Clinical Trials
Recruiting NCT05854160

NCT05854160 Stimulation-Induced Changes in Fronto-Limbic Network

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05854160
Status Recruiting
Phase
Sponsor University of Alabama at Birmingham
Condition Epilepsy
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2023-03-01
Primary Completion 2027-04-30

Trial Parameters

Condition Epilepsy
Sponsor University of Alabama at Birmingham
Study Type INTERVENTIONAL
Phase N/A
Enrollment 30
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2023-03-01
Completion 2027-04-30
Interventions
Electrical Pulse Train Stimulation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The purpose of this research is to better understand how emotion processing unfolds in the brain using stereoelectroencephalography (sEEG) and direct brain stimulation. This study will use standard behavioral emotion processing tasks combined with neural recording and direct brain stimulation to assess different aspects of emotion processing. Stimulation pulses during pre and post-test periods will assess the effects of stimulation before and after conditioning, the results of which will be combined with results from the activity of each electrode during the emotion tasks to inform us of the nature of emotion processing in the brain and allow us to devise brain modulation protocols in the future.

Eligibility Criteria

Inclusion Criteria: * 1\) implantation of sEEG electrodes for SOC epilepsy surgery evaluation * 2\) cognitive ability to perform simple tasks and to understand instructions * 3\) implanted electrodes in the amygdala and medial PFC regions * 4\) competency to understand and sign a written informed consent. Exclusion Criteria: * 1\) an inability to complete the task

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology